Trump signs order to research psychedelic used abroad to treat PTSD

President Trump signed an executive order to facilitate research into ibogaine, a psychedelic drug used abroad for treating PTSD, according to CBS News sources. The order aims to open new pathways for studying the drug's therapeutic potential.